Former pro baseball player receives vital diagnosis from new noninvasive coronary artery test
Loyola is the first hospital in Illinois to offer HeartFlow® fractional flow reserve-computed tomography (FFRCT), a new, noninvasive technology to test for heart disease. HeartFlow® employs noninvasive CT scans to calculate how much blood is flowing through diseased coronary arteries that have narrowed due to plaque. As a result, the patient does not need an invasive angiogram that involves threading a catheter to the heart. HeartFlow® can benefit patients who have experienced symptoms such as chest pain and shortness of breath, but have not been diagnosed with heart disease. For more information, please visit https://www.loyolamedicine.org or call 888-584-7888.